Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ADH1B | P00325 | 1/20 | 0.34 |
| ▸ | ADH1C | P00326 | 1/20 | 0.34 |
| ▸ | ADH1A | P07327 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3340519 | 1.00 | THRB (0.41) | THRBMEN1KMT2AADH1BADH1C | |
| SCHEMBL28370158 | 0.82 | THRB (0.32) | THRBMEN1KMT2A | |
| SCHEMBL6658499 | 0.82 | ADH1B (0.41) | ADH1BADH1CADH1A | |
| SCHEMBL17426952 | 0.82 | ADH1B (0.41) | ADH1BADH1CADH1A | |
| SCHEMBL17426973 | 0.82 | ADH1B (0.41) | ADH1BADH1CADH1A | |
| SCHEMBL4302896 | 0.79 | THRB (0.39) | THRBMEN1KMT2A | |
| SCHEMBL13264341 | 0.79 | THRB (0.33) | THRBMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL6657586 | 0.77 | ADH1B (0.38) | ADH1BADH1CADH1A | |
| SCHEMBL187419 | 0.72 | THRB (0.47) | THRBMEN1KMT2A | |
| SCHEMBL13993045 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112441984-B | Benzimidazole-substituted phenyl n-butyramide-based compound and preparation method thereof | 上海特化医药科技有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-112441984-B | Benzimidazole-substituted phenyl n-butyramide-based compound and preparation method thereof | 上海特化医药科技有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-116947843-A | 3, 5-disubstituted benzothia (oxa) azole compounds, synthesis and application thereof | 西北农林科技大学 | 2023-10-27 | — | — | CN | disclosed |
| US-20090326229-A1 | ALPHA-CARBOLINE DERIVATIVES AND METHODS FOR PREPARATION THEREOF | TAKEDA PHAMACEUTICAL COMPANY LIMITED (JP) | 2009-12-31 | — | — | US | disclosed |
| EP-1160267-B1 | CATALYST FOR OXIDATIVE POLYMERIZATION OF FLUOROPHENOL, METHOD OF OXIDATIVE POLYMERIZATION OF FLUOROPHENOL, AND POLY(OXYFLUOROPHENYLENE) DERIVATIVE | JAPAN SCIENCE & TECH CORP (JP) | 2004-08-04 | — | — | EP | disclosed |
| US-6689919-B1 | SOLUBLE POLY(OXYFLUOROPHENYLENE) COMPOUNDS WITH EXCELLENT HEAT RESISTANCE, MEMBRANE-FORMABILITY AND CHEMICAL STABILITY | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2004-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090326229-A1 | ALPHA-CARBOLINE DERIVATIVES AND METHODS FOR PREPARATION THEREOF | XDH, F7, CYP4X1 | THRB 2927/4885MEN1 1244/4885KMT2A 566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.